Multicenter Studies as Topic
"Multicenter Studies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
| Descriptor ID |
D015337
|
| MeSH Number(s) |
E05.318.760.658 N05.715.360.775.508 N06.850.520.450.643
|
| Concept/Terms |
Multicenter Trials- Multicenter Trials
- Multicenter Trial
- Trial, Multicenter
- Trials, Multicenter
- Multicentre Trials
- Multicentre Trial
- Trial, Multicentre
- Trials, Multicentre
|
Below are MeSH descriptors whose meaning is more general than "Multicenter Studies as Topic".
Below are MeSH descriptors whose meaning is more specific than "Multicenter Studies as Topic".
This graph shows the total number of publications written about "Multicenter Studies as Topic" by people in this website by year, and whether "Multicenter Studies as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 6 | 6 |
| 2006 | 1 | 12 | 13 |
| 2007 | 1 | 4 | 5 |
| 2008 | 1 | 4 | 5 |
| 2009 | 0 | 6 | 6 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 5 | 5 |
| 2012 | 3 | 7 | 10 |
| 2013 | 4 | 3 | 7 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 3 | 5 |
| 2017 | 0 | 2 | 2 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 9 | 9 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 8 | 8 |
| 2024 | 0 | 6 | 6 |
| 2025 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.
-
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC. Future Oncol. 2025 Jul; 21(16):2007-2016.
-
A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS). Trials. 2025 May 30; 26(1):181.
-
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1).
-
Protocol for an international multicenter, prospective, observational, non-competitive, study to validate and optimise prediction models of 90-day and 1-year allograft failure after liver transplantation: The global IMPROVEMENT Study. Updates Surg. 2025 Jun; 77(3):645-664.
-
Design and rationale for the clinical investigation of a novel, magnetically levitated left ventricular assist device for the treatment of refractory heart failure. J Heart Lung Transplant. 2025 Aug; 44(8):1290-1299.
-
Association between prehospital tranexamic acid and cerebral edema in patients with moderate or severe traumatic brain injury. J Trauma Acute Care Surg. 2025 May 01; 98(5):794-797.
-
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis. BMJ Open Gastroenterol. 2025 Jan 08; 12(1).
-
Semaglutide 2.4?mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial. Aliment Pharmacol Ther. 2024 Dec; 60(11-12):1525-1533.
-
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer. Clin Lung Cancer. 2024 Dec; 25(8):e448-e452.
-
Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion (GET FAB): protocol for a multisite Canadian randomised controlled trial. BMJ Open. 2024 07 01; 14(6):e086602.